ELOVL2 and posterior cortical atrophy: Importantly, the positive correlation between ELOVL2 and AR levels in enzalutamide-resistant PCa cells reveals a potential functional interplay between ELOVL2-mediated fatty acid metabolism and AR signaling in driving therapeutic resistance.